Avidity Biosciences Inc
RNA
Market Cap$2.02B
Close$
$-4.57
119.8% downside
Current Fair Value
119.8% downsideOvervalued by 119.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.02 Billion |
|---|---|
| Enterprise Value | $1.44 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.91 |
| Beta | 1.04 |
| Outstanding Shares | 79,719,473 |
| Avg 30 Day Volume | 1,269,005 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.52 |
|---|---|
| PEG | -48.2 |
| Price to Sales | - |
| Price to Book Ratio | 3.84 |
| Enterprise Value to Revenue | 150.15 |
| Enterprise Value to EBIT | -6.09 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
ESG Score
No data